Nuvo/Mallinckrodt’s Pennsaid Setback Starts Clock On Generic Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
With Nuvo’s new Pennsaid 2% formulation hung up at FDA, Apotex may be able to launch its generic of the old 1.5% formulation of the topical diclofenac product on April 1, 2014, under a settlement announced in January.